Strikingly there was a statistically significant increased number of CPFE patients presenting with elevated (>1/160) serum titers of ANA (n = 17/40, 42.5%) compared to patients with IPF (n = 16/60, 26.6%), (p < 0.05) (Table 3). Here, BTG3 is linked to idiopathic pulmonary fibrosis.